The American Society for Radiation Oncology (ASTRO) has reviewed and approved these symposia as appropriate for presentation as an Industry Satellite Symposium. The symposia constitute the content and views of the provider and are not part of the official ASTRO Annual Meeting program.
6:15 p.m. - 8:45 p.m.: Dinner and Symposium
GU Tumor Board: Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies
Location: San Francisco Marriott Marquis
Nob Hill A-D
780 Mission Street
San Francisco, CA 94103
CME Credits: Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™ and two contact hours for nurses. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience: This educational activity is directed toward ASTRO congress attendees, including audience of radiation oncologists, medical oncologists, APPs, nurses and pharmacists involved in the diagnosis and management of patients with prostate cancer.
Learning Objectives:
Topics: This activity will cover integrating PSMA PET imaging into diagnosis/staging/ treatment planning, sequencing and integrating PSMA-targeting therapies in mCRPC, as well as novel therapies and emerging treatment strategies for prostate cancer management. These topics will be the primary focus points of this activity, along with additional pressing controversies surrounding the management of prostate cancer.
Faculty: TBD
This activity is independently supported through an educational grant from Lantheus, Novartis Pharmaceuticals Corporation, and Blue Earth Diagnostics.
6:30 p.m. - 8:00 p.m.: Dinner and Symposium
Clinical Integration of Therapeutic Innovations in IDH-Mutant Glio
Pathways to Improved Patient Outcomes
Location: San Francisco Marriott Marquis
Golden Gate A
780 Mission Street
San Francisco, CA 94103
CME Credits: MedscapeLIVE designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience: This educational activity is intended for an audience of radiation oncologists, medical oncologists, neuro-oncologists, neurosurgeons, radiologists and the rest of the oncology care team.
Learning Objectives: Upon completion of this activity, participants will:
Have increased knowledge regarding the latest clinical data evaluating novel and emerging therapies targeting IDH mutations in patients with gliomas.
Have greater competence related to tailoring treatment for patients with IDH--mutant glioma.
Demonstrate greater confidence in their ability to work effectively within the MDT to integrate novel targeted therapy for glioma into existing clinical practice.
Agenda:
Faculty: TBD
This activity is independently supported through an educational grant from Servier.
6:30 p.m. - 8:00 p.m.: Symposium
Mastering Complexity: A Multimodal, Integrated Approach to Brain Metastases Management
Location: The Clancy, Autograph Collection
Lotline Ballroom
299 2nd Street
San Francisco, CA 94105
CME Credits: This is a non-CME program.
Target Audience: Radiation and medical oncologists and neurosurgeons.
Learning Objectives: Educate on current treatment options and unmet needs for patients with brain metastases from metastatic NSCLC.
Program Agenda:
Faculty: TBD
This activity is independently organized by Novocure GmbH.
